Inflammasomes are large protein complexes that result in aberrant/increased cytokine production in more than twenty-four different prevalent and rare inflammatory diseases.  The immense interest in targeting inflammasomes for treating diseases has been well established, as demonstrated by the growing list of scientific publications, the ongoing public and private investments in this field and acquisitions of inflammasome focused companies by large pharmaceutical companies. 

​

IMMvention is developing therapies that inhibit multiple inflammasome pathways that result in increased cytokine production that at the root cause of some of the following diseases.